Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Thrombectomy, IVC filters & venous stents · Utah | Thrombectomy, IVC filters & venous stents · California | |
|---|---|---|
| Surgeons, 2024 | 0 | 42 |
| Medicare fee-for-service cases | 253 | 4,550 |
| Growth since 2019 (Medicare FFS) | +3.2%/yr | +3.4%/yr |
| Forecast cases (Medicare FFS) | 480 in 2030 | 6,830 in 2030 |
| Forecast growth | +11%/yr to 2030 | +7%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 1.2 | 1.4 |
| Medicare Advantage share | 57% | 56% |
| Out of hospital | 0% (−20 pts since 2019) | 29% (+10 pts since 2019) |
| Cases per surgeon | – | 108 |
| Top 10 surgeons' share | – | 62% |
| Surgeons growing | 0 | 3 |
| New since the base year | 0 | 8 |
| Likely to stop billing it | 0 by 2026 | 22 by 2026 |
| Forecast miss, 1 year (procedure) | 9% | 9% |
| Company payments per surgeon | – | $30K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.